Year-end Sale % OFF 
Abstract
Since 1921, we 1 have tried to standardize a therapeutic regimen for patients afflicted with disturbances of the thyroid gland or of the involuntary nervous system. Many unsolved physiologic and clinical problems have rendered our efforts only partially successful. However, necessity compels the therapeutist to evolve a working program and this we shall attempt in what is to follow. Patients are classified in three groups: (1) those with morphologic changes in the thyroid gland (simple goiter 2 ) but without sympathomimetic symptoms (autonomic imbalance; vide infra) or elevation of the basal metabolic rate; (2) those with sympathomimetic symptoms (autonomic imbalance 3 ) but without elevation of the basal metabolic rate and with or without goiter; (3) those with autonomic imbalance, goiter and definite and sustained elevation of the basal metabolic rate (exophthalmic goiter, the Graves syndrome and Basedow's disease 4 ). MANAGEMENT OF THE PATIENT Simple Goiter (Group 1). —Therapy in this condition
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
